TFINITY Trademark

Trademark Overview

On Thursday, August 18, 2016, a trademark application was filed for TFINITY with the United States Patent and Trademark Office. The USPTO has given the TFINITY trademark a serial number of 87143602. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 10, 2020. This trademark is owned by Fate Therapeutics, Inc.. The TFINITY trademark is filed in the Pharmaceutical Products category with the following description:

Cells for medical use; therapeutic cell preparation for the treatment of cancer, infectious diseases, and immune disorders; therapeutic agents for the modulation of cells for use as immunotherapies; pharmaceutical preparations for the treatment of cancer, infectious diseases, and immune disorders; kits comprised of cells and pharmaceutical preparations for the treatment of cancer, infectious diseases, and immune disorders for medical or clinical use; bio-engineered component for a therapeutic material, namely, cell lines for medical or clinical use used for immunotherapy
tfinity

General Information

Serial Number87143602
Word MarkTFINITY
Filing DateThursday, August 18, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 10, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 9, 2017

Trademark Statements

Goods and ServicesCells for medical use; therapeutic cell preparation for the treatment of cancer, infectious diseases, and immune disorders; therapeutic agents for the modulation of cells for use as immunotherapies; pharmaceutical preparations for the treatment of cancer, infectious diseases, and immune disorders; kits comprised of cells and pharmaceutical preparations for the treatment of cancer, infectious diseases, and immune disorders for medical or clinical use; bio-engineered component for a therapeutic material, namely, cell lines for medical or clinical use used for immunotherapy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 24, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFate Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameFate Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, August 10, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 10, 2020ABANDONMENT - NO USE STATEMENT FILED
Friday, January 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 9, 2020EXTENSION 5 GRANTED
Friday, January 3, 2020EXTENSION 5 FILED
Thursday, January 9, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 3, 2020TEAS EXTENSION RECEIVED
Friday, July 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 3, 2019EXTENSION 4 GRANTED
Wednesday, July 3, 2019EXTENSION 4 FILED
Wednesday, July 3, 2019TEAS EXTENSION RECEIVED
Tuesday, December 25, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 21, 2018EXTENSION 3 GRANTED
Friday, December 21, 2018EXTENSION 3 FILED
Friday, December 21, 2018TEAS EXTENSION RECEIVED
Wednesday, June 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 25, 2018EXTENSION 2 GRANTED
Monday, June 25, 2018EXTENSION 2 FILED
Monday, June 25, 2018TEAS EXTENSION RECEIVED
Thursday, January 4, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 2, 2018EXTENSION 1 GRANTED
Tuesday, January 2, 2018EXTENSION 1 FILED
Tuesday, January 2, 2018TEAS EXTENSION RECEIVED
Tuesday, July 4, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 9, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 9, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 19, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 20, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 17, 2017EXAMINER'S AMENDMENT ENTERED
Friday, March 17, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 17, 2017EXAMINERS AMENDMENT E-MAILED
Friday, March 17, 2017EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 27, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 27, 2016NON-FINAL ACTION E-MAILED
Tuesday, September 27, 2016NON-FINAL ACTION WRITTEN
Friday, September 16, 2016ASSIGNED TO EXAMINER
Wednesday, August 24, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 22, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

tfinity infectious diseases disorders cells cancer immune treatment therapeutic medical pharmaceutical